{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:12:47Z","timestamp":1777407167827,"version":"3.51.4"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11910-021-01128-9","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T21:03:27Z","timestamp":1622840607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Approach to Pediatric Intractable Migraine"],"prefix":"10.1007","volume":"21","author":[{"given":"Mohammed","family":"Alqahtani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Barmherzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4859-6216","authenticated-orcid":false,"given":"Ana Marissa","family":"Lagman-Bartolome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"issue":"1 Pt1","key":"1128_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.112.1.e1","volume":"112","author":"SW Powers","year":"2003","unstructured":"Powers SW, Patton SR, Hommel KA, Hershey AD. Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses. Pediatrics. 2003;112(1 Pt1):1\u20135.","journal-title":"Pediatrics"},{"key":"1128_CR2","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1177\/0333102409355601","volume":"30","author":"TW Victor","year":"2010","unstructured":"Victor TW, Hu X, Campbell JC, Buse DC, Lipton RB. Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia. 2010;30:1065\u201372.","journal-title":"Cephalalgia."},{"issue":"5","key":"1128_CR3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1526-4610.2011.01885.x","volume":"51","author":"RB Lipton","year":"2011","unstructured":"Lipton RB, Manack A, Ricci JA, Chee E, Turkel CC, Winner P. Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS). Headache. 2011;51(5):693\u2013706.","journal-title":"Headache."},{"key":"1128_CR4","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/j.1468-2982.2006.01173.x","volume":"26","author":"PJ Goadsby","year":"2006","unstructured":"Goadsby PJ, Schoenen J, Ferrari MD, Silberstein SD, Dodick D. Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia. 2006;26:1168\u201370.","journal-title":"Cephalalgia."},{"issue":"1","key":"1128_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s10194-019-1040-x","volume":"20","author":"L D\u2019Antona","year":"2019","unstructured":"D\u2019Antona L, Matharu M. Identifying and managing refractory migraine: barriers and opportunities? J Headache Pain. 2019;20(1):89.","journal-title":"J Headache Pain"},{"issue":"5","key":"1128_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11916-005-0014-7","volume":"9","author":"MA Kabbouche","year":"2005","unstructured":"Kabbouche MA, Linder SL. Management of migraine in children and adolescents in the emergency department and inpatient setting. Curr Pain Headache Rep. 2005;9(5):363\u20137.","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"1128_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1474-4422(17)30435-0","volume":"17","author":"A Charles","year":"2018","unstructured":"Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. 2018;17(2):174\u201382.","journal-title":"Lancet Neurol"},{"issue":"17","key":"1128_CR8","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","volume":"35","author":"R Burstein","year":"2015","unstructured":"Burstein R, Noseda R, Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci. 2015;35(17):6619\u201329.","journal-title":"J Neurosci"},{"issue":"2\u20133","key":"1128_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0304-3959(00)00478-4","volume":"89","author":"R Burstein","year":"2001","unstructured":"Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain. 2001;89(2\u20133):107\u201310.","journal-title":"Pain."},{"key":"1128_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"90","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Marins-Liveira M, et al. Pathophysiology of migraine. A disorder of sensory processing. Physiol Rev. 2017;90:553\u2013622.","journal-title":"Physiol Rev"},{"key":"1128_CR11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","volume":"18","author":"M Ashina","year":"2019","unstructured":"Ashina M, Hansen JM, Do TP, MeloCarrillo A, Burstein R, Moskowitz MA. Migraine and the trigeminovascular system\u201440 years and counting. Lancet Neurol. 2019;18:795\u2013804.","journal-title":"Lancet Neurol"},{"issue":"9","key":"1128_CR12","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","volume":"10","author":"A Latremoliere","year":"2009","unstructured":"Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895\u2013926.","journal-title":"J Pain"},{"issue":"6","key":"1128_CR13","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1526-4610.2008.01158.x","volume":"48","author":"DW Dodick","year":"2008","unstructured":"Dodick DW. Reflections and speculations on refractory migraine: why do some patients fail to improve with currently available therapies? Headache. 2008;48(6):828\u201337.","journal-title":"Headache."},{"issue":"4","key":"1128_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/head.12047","volume":"53","author":"Schulman E . Refractory migraine-a review","year":"2013","unstructured":"Schulman E . Refractory migraine-a review. Refractory Migraine - A Review. Headache. 2013;53(4):599\u2013613.","journal-title":"Headache."},{"key":"1128_CR15","doi-asserted-by":"crossref","unstructured":"Orr, S.L., Kabbouche, M.A., O\u2019Brien, H.L. et al. Paediatric migraine: evidence-based management and future directions. Nat Rev Neurol. 2018;14, 515\u2013527. This is a comprehensive review of evidence-based management of pediatric migraine focusing on goals of therapy as well as multidisciplinary approach treatment strategies and pharmacologic treatment.","DOI":"10.1038\/s41582-018-0042-7"},{"key":"1128_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/head.13459","volume":"59","author":"DC Buse","year":"2019","unstructured":"Buse DC, Greisman JD, Baigi K, Lipton RB. Migraine progression: a systematic review. Headache. 2019;59:306\u201338.","journal-title":"Headache"},{"key":"1128_CR17","doi-asserted-by":"crossref","unstructured":"Werner K, Qaiser S, Kabbouche M, Murphy B, Maconochie I, Hershey AD. Intravenous migraine treatment in children and adolescents. Curr Pain Headache Rep. 2020 8;24(8):45. This is a review of the different intravenous migraine treatment in children and adolescents used in the emergency department or inpatient setting.","DOI":"10.1007\/s11916-020-00867-7"},{"issue":"10","key":"1128_CR18","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/head.12233","volume":"53","author":"E Loder","year":"2013","unstructured":"Loder E, Weizenbaum E, Frishberg B, Silberstein S. American Headache Society Choosing Wisely Task Force. Choosing wisely in headache medicine: the American Headache Society\u2019s list of five things physicians and patients should question. Headache. 2013;53(10):1651\u20139.","journal-title":"Headache."},{"key":"1128_CR19","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/head.12399","volume":"54","author":"MT Minen","year":"2014","unstructured":"Minen MT, Tanev K, Friedman BW. Evaluation and treatment of migraine in the emergency department: a review. Headache: The Journal of Head and Face Pain. 2014;54:1131\u201345.","journal-title":"Headache: The Journal of Head and Face Pain"},{"key":"1128_CR20","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1542\/peds.2009-2337","volume":"126","author":"LP Richer","year":"2010","unstructured":"Richer LP, Laycock K, Millar K, Fitzpatrick E, Khangura S, Bhatt M, et al. Treatment of children with migraine in emergency departments: national practice variation study. Pediatrics. 2010;126:e150\u20135.","journal-title":"Pediatrics."},{"key":"1128_CR21","doi-asserted-by":"crossref","unstructured":"Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, Gloss D, Hershey AD, Licking N, Sowell M, Victorio MC, Gersz EM, Leininger E, Zanitsch H, Yonker M, Mack K. Practice guideline update summary: acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Headache. 2019;59(8):1158-1173. This is a comprehensive guideline providing an updated evidence-based recommendation on pharmacologic management for acute treatment of in children and adolescents.","DOI":"10.1111\/head.13628"},{"key":"1128_CR22","doi-asserted-by":"crossref","unstructured":"Szperka CL, Ailani J, Barmherzig R, et al, Migraine care in the era of COVID-19: clinical pearls and plea to insurers.Headache.2020;60:833-842 This is a review article on using different treatment evidence-based and \u201creal world\u201d strategies for migraine treatment including acute, bridge, and preventive therapies which may be tried for which do not require in-person visits to clinic or the emergency department in the era of COVID-19 pandemic.","DOI":"10.1111\/head.13810"},{"issue":"10","key":"1128_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224285","volume":"14","author":"PW Chi","year":"2019","unstructured":"Chi PW, Hsieh KY, Chen KY, Hsu CW, Bai CH, Chen C, et al. Intranasal lidocaine for acute migraine: a meta-analysis of randomized controlled trials. PLoS One. 2019;14(10):e0224285.","journal-title":"PLoS One"},{"issue":"8","key":"1128_CR24","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1001\/jamaneurol.2018.0970","volume":"75","author":"M Cossack","year":"2018","unstructured":"Cossack M, Nabrinsky E, Turner H, Abraham A, Gratton S. Timolol eyedrops in the treatment of acute migraine attacks: a randomized crossover study. JAMA Neurol. 2018;75(8):1024\u20135.","journal-title":"JAMA Neurol"},{"issue":"11","key":"1128_CR25","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1001\/jamaophthalmol.2020.3676","volume":"138","author":"A Kurian","year":"2020","unstructured":"Kurian A, Reghunadhan I, Thilak P, Soman I, Nair U. Short-term efficacy and safety of topical \u03b2-blockers (timolol maleate ophthalmic solution, 0.5%) in acute migraine: a randomized crossover trial. JAMA Ophthalmol. 2020;138(11):1160\u20136.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"1128_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006565-199702000-00001","volume":"13","author":"LJ Burton","year":"1997","unstructured":"Burton LJ, Quinn B, Pratt-Cheney JL, Pourani M. Headache etiology in a pediatric emergency department. Pediatr Emerg Care. 1997;13(1):1\u20134.","journal-title":"Pediatr Emerg Care"},{"issue":"2","key":"1128_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jpeds.2014.04.053","volume":"165","author":"D Massano","year":"2014","unstructured":"Massano D, Julliand S, Kanagarajah L, Gautier M, Vizeneux A, Elmaleh M, et al. Headache with focal neurologic signs in children at the emergency department. J Pediatr. 2014;165(2):376\u201382.","journal-title":"J Pediatr"},{"issue":"15","key":"1128_CR28","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1177\/0333102411425960","volume":"31","author":"RP Insinga","year":"2011","unstructured":"Insinga RP, Ng-Mark DS. Hanson ME Costs associated with out-patient, emergency room and inpatient care for migraine in the USA. Cephalgia. 2011;31(15):1570\u20135.","journal-title":"Cephalgia"},{"key":"1128_CR29","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/head.12443","volume":"54","author":"L Richer","year":"2014","unstructured":"Richer L, Craig W, Rowe B. Randomized controlled trial of treatment expectation and intravenous fluid in pediatric migraine. Headache: The Journal of Head and Face Pain. 2014;54:1496\u2013505.","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"5","key":"1128_CR30","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1213\/ANE.0b013e31828a4b54","volume":"116","author":"M Bloor","year":"2013","unstructured":"Bloor M, Paech M. Nonsteroidal anti-inflammatory drugs during pregnancy and the initiation of lactation. Anesth Analg. 2013;116(5):1063\u201375.","journal-title":"Anesth Analg"},{"issue":"2","key":"1128_CR31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0196-0644(03)00716-9","volume":"43","author":"DC Brousseau","year":"2004","unstructured":"Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med. 2004;43(2):256\u201362.","journal-title":"Ann Emerg Med"},{"issue":"3","key":"1128_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/PEC.0000000000000718","volume":"34","author":"DC Sheridan","year":"2018","unstructured":"Sheridan DC, Laurie A, Pacheco S, Fu R, Hansen ML, Ma OJ, et al. Relative effectiveness of dopamine antagonists for pediatric migraine in the emergency department. Pediatr Emerg Care. 2018;34(3):165\u20138.","journal-title":"Pediatr Emerg Care"},{"key":"1128_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1542\/peds.2014-2432","volume":"135","author":"RG Bachur","year":"2015","unstructured":"Bachur RG, Monuteaux MC, Neuman MI. A comparison of acute treatment regimens for migraine in the emergency department. Pediatrics. 2015;135:232\u20138.","journal-title":"Pediatrics."},{"key":"1128_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0083-6729(04)69011-X","volume":"69","author":"A Bianchi","year":"2004","unstructured":"Bianchi A, Salomone S, Caraci F, Pizza V, Bernardini R, D\u2019Amato CC. Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis. Vitam Horm. 2004;69:297\u2013312.","journal-title":"Vitam Horm"},{"key":"1128_CR35","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1152\/jn.1987.57.3.869","volume":"57","author":"I Mody","year":"1987","unstructured":"Mody I, Lambert JDC, Heinemann V. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol. 1987;57:869\u201388.","journal-title":"J Neurophysiol"},{"key":"1128_CR36","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1203\/00006450-199712000-00024","volume":"42","author":"R Lodi","year":"1997","unstructured":"Lodi R, Montagna P, Soriani S, Iotti S, Arnaldi C, Cortelli P, et al. Deficit of brain and skeletal muscle bioenergetics and low brain magnesium in juvenile migraine: an in vivo 31P magnetic resonance spectroscopy interictal study. Pediatr Res. 1997;42:866\u201371.","journal-title":"Pediatr Res"},{"issue":"1","key":"1128_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jemermed.2014.06.055","volume":"48","author":"A Shahrami","year":"2015","unstructured":"Shahrami A, Assarzadegan F, Hatamabadi HR, Asgarzadeh M, Sarehbandi B, Asgarzadeh S. Comparison of therapeutic effects of magnesium sulfate vs. dexamethasone\/metoclopramide on alleviating acute migraine headache. J Emerg Med. 2015;48(1):69\u201376.","journal-title":"J Emerg Med"},{"issue":"3","key":"1128_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1046\/j.1526-4610.1996.3603154.x","volume":"36","author":"A Mauskop","year":"1996","unstructured":"Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache. 1996;36(3):154\u201360.","journal-title":"Headache."},{"key":"1128_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/0333102414535997","volume":"35","author":"SL Orr","year":"2015","unstructured":"Orr SL, Aube A, Becker WJ, et al. Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings. Cephalalgia. 2015;35:271\u201384.","journal-title":"Cephalalgia."},{"key":"1128_CR40","first-page":"2","volume":"21","author":"H Choi","year":"2014","unstructured":"Choi H, Parmar N. The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials. Eur J Emerg Med. 2014;21:2\u20139.","journal-title":"Eur J Emerg Med"},{"key":"1128_CR41","unstructured":"Martinez Cardenas V, Rodriguez M, Burke M, et al. Efficacy and safety of intravenous magnesium sulfate treatment in pediatric patients with headaches. Headache. 2012; 52: 896."},{"issue":"2","key":"1128_CR42","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jemermed.2013.08.049","volume":"46","author":"E Gertsch","year":"2014","unstructured":"Gertsch E, Loharuka S, Wolter-Warmerdam K, Tong S, Kempe A, Kedia S. Intravenous magnesium as acute treatment for headaches: a pediatric case series. J Emerg Med. 2014;46(2):308\u201312.","journal-title":"J Emerg Med"},{"key":"1128_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.earlhumdev.2010.02.007","volume":"86","author":"K Yokoyama","year":"2010","unstructured":"Yokoyama K, Takahashi N, Yada Y. Prolonged maternal magnesium administration and bone metabolism in neonates. Early Hum Dev. 2010;86:187\u201391.","journal-title":"Early Hum Dev"},{"issue":"1","key":"1128_CR44","first-page":"26","volume":"467","author":"A Palermo","year":"2009","unstructured":"Palermo A, Fierro B, Giglia G, Cosentino G, Puma AR, Brighina F. Neurosci Lett. Modulation of visual cortex excitability in migraine with aura: effects of valproate therapy. 2009;467(1):26\u20139.","journal-title":"Modulation of visual cortex excitability in migraine with aura: effects of valproate therapy"},{"issue":"4","key":"1128_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1600-0404.2010.01394.x","volume":"123","author":"R Shahien","year":"2011","unstructured":"Shahien R, Saleh SA, Bowirrat A. Intravenous sodium valproate aborts migraine headaches rapidly. Acta Neurol Scand. 2011;123(4):257\u201365.","journal-title":"Acta Neurol Scand"},{"issue":"10","key":"1128_CR46","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1046\/j.1526-4610.2001.01191.x","volume":"41","author":"KR Edwards","year":"2001","unstructured":"Edwards KR, Norton J, Behnke M. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache. 2001;41(10):976\u201380.","journal-title":"Headache."},{"issue":"6","key":"1128_CR47","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1212\/01.WNL.0000052998.58526.A9","volume":"60","author":"NJ Giffin","year":"2003","unstructured":"Giffin NJ, Ruggiero L, Lipton RB, Silberstein SD, Tvedskov JF, Olesen J, et al. Premonitory symptoms in migraine: an electronic diary study. Neurology. 2003;60(6):935\u201340.","journal-title":"Neurology."},{"issue":"4","key":"1128_CR48","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/emj.2007.047860","volume":"24","author":"P Loga","year":"2007","unstructured":"Loga P, Lewis D. Compazine in migraine. Emergency Medicine Journal (BMJ). 2007;24(4):297\u20138.","journal-title":"Emergency Medicine Journal (BMJ)"},{"issue":"10","key":"1128_CR49","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0196-0644(05)81507-0","volume":"19","author":"R Bell","year":"1990","unstructured":"Bell R, Montoya D, Shuaib A, Lee MA. A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med. 1990;19(10):1079\u201382.","journal-title":"Ann Emerg Med"},{"issue":"1","key":"1128_CR50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1526-4610.2005.05009.x","volume":"45","author":"T Leniger","year":"2005","unstructured":"Leniger T, Pageler L, Stude P, Diener HC, Limmroth V. Comparison of intravenous valproate with intravenous lysine-acetylsalicylic acid in acute migraine attacks. Headache. 2005;45(1):42\u20136.","journal-title":"Headache."},{"issue":"6","key":"1128_CR51","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1067\/mem.2003.195","volume":"41","author":"DA Tanen","year":"2003","unstructured":"Tanen DA, Miller S, French T, Riffenburgh RH. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. Ann Emerg Med. 2003;41(6):847\u201353.","journal-title":"Ann Emerg Med"},{"issue":"2","key":"1128_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/NRL.0000000000000161","volume":"23","author":"MS Zafar","year":"2018","unstructured":"Zafar MS, Stewart AM, Toupin DN, Cook AM, Baumann RJ. Continuous intravenous valproate as abortive therapy for pediatric status migrainosus. Neurologist. 2018;23(2):43\u20136.","journal-title":"Neurologist."},{"issue":"4","key":"1128_CR53","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jemermed.2015.02.024","volume":"49","author":"D Sheridan","year":"2015","unstructured":"Sheridan D, Sun B, O\u2019Brien P, Hansen M. Intravenous sodium valproate for acute pediatric headache. J Emerg Med. 2015;49(4):541\u20135.","journal-title":"J Emerg Med"},{"issue":"7","key":"1128_CR54","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1526-4610.2005.05158.x","volume":"45","author":"PD Reiter","year":"2005","unstructured":"Reiter PD, Nickisch J, Merritt G. Efficacy and tolerability of intravenous valproic acid in acute adolescent migraine. Headache. 2005;45(7):899\u2013903.","journal-title":"Headache."},{"issue":"2","key":"1128_CR55","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/head.12255","volume":"54","author":"JM Kanis","year":"2014","unstructured":"Kanis JM, Timm NL. Chlorpromazine for the treatment of migraine in a pediatric emergency department. Headache. 2014;54(2):335\u201342.","journal-title":"Headache."},{"key":"1128_CR56","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jpeds.2016.08.050","volume":"179","author":"DC Sheridan","year":"2016","unstructured":"Sheridan DC, Meckler GD. Inpatient pediatric migraine treatment: does choice of abortive therapy affect length of stay? J Pediatr. 2016;179:211\u20135.","journal-title":"J Pediatr"},{"key":"1128_CR57","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1046\/j.1526-4610.2000.00125.x","volume":"40","author":"NT Mathew","year":"2000","unstructured":"Mathew NT, Kailasam J, Meadors L, Chernschev O, Gentry P. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache. 2000;40:720\u20137.","journal-title":"Headache."},{"issue":"1","key":"1128_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00655.x","volume":"114","author":"N Segura-Bruna","year":"2006","unstructured":"Segura-Bruna N, Rodriguez-Campello A, Puente V, Roquer J. Valproate-induced hyperammonemic encephalopathy. Acta Neurol Scand. 2006;114(1):1\u20137.","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"1128_CR59","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41582-019-0216-y","volume":"15","author":"L Edvinsson","year":"2019","unstructured":"Edvinsson L, Haanes KA, Warfvinge K. Does inflammation have a role in migraine? Nat Rev Neurol. 2019;15(8):483\u201390.","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"1128_CR60","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/head.12835","volume":"56","author":"SL Orr","year":"2016","unstructured":"Orr SL, Friedman BW, Christie S, Minen MT, Bamford C, Kelley NE, et al. Management of adults with acute migraine in the emergency department: the American Headache Society evidence assessment of parenteral pharmacotherapies. Headache. 2016;56(6):911\u201340.","journal-title":"Headache."},{"issue":"10","key":"1128_CR61","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/head.12654","volume":"55","author":"KM Cobb-Pitstick","year":"2015","unstructured":"Cobb-Pitstick KM, Hershey AD, O\u2019Brien HL, Kabbouche MA, LeCates S, White S, et al. Factors influencing migraine recurrence after infusion and inpatient migraine treatment in children and adolescents. Headache. 2015;55(10):1397\u2013403.","journal-title":"Headache."},{"key":"1128_CR62","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1526-4610.1994.hed3410578.x","volume":"34","author":"SL Linder","year":"1994","unstructured":"Linder SL. Treatment of childhood headache with DHE. Headache. 1994;34:578\u201380.","journal-title":"Headache."},{"key":"1128_CR63","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1526-4610.2008.01293.x","volume":"49","author":"MA Kabbouche","year":"2009","unstructured":"Kabbouche MA, Powers SW, Segers A, LeCates S, Manning P, Biederman S, et al. Treatment of status migraine with dihydroergotamine in children and adolescents. Headache. 2009;49:106\u20139.","journal-title":"Headache."},{"key":"1128_CR64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1941874412439583","volume":"2","author":"AA Gelfand","year":"2012","unstructured":"Gelfand AA, Goadsby PJ. A neurologist\u2019s guide to acute migraine therapy in the emergency room. Neurohospitalist. 2012;2:51\u20139.","journal-title":"Neurohospitalist."},{"key":"1128_CR65","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0196-0644(98)70126-X","volume":"32","author":"SC Carleton","year":"1998","unstructured":"Carleton SC, Shesser RF, Pietrzak MP, Chudnofsky CR, Starkman S, Morris D, et al. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache. Ann Emerg Med. 1998;32:129\u20131389.","journal-title":"Ann Emerg Med"},{"key":"1128_CR66","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1212\/WNL.36.7.995","volume":"36","author":"NH Raskin","year":"1986","unstructured":"Raskin NH. Repetitive intravenous DHE therapy for intractable migraine. Neurology. 1986;36:995\u20137.","journal-title":"Neurology."},{"key":"1128_CR67","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1526-4610.1986.hed2604168.x","volume":"26","author":"M Callaham","year":"1986","unstructured":"Callaham M, Raskin N. A controlled study of DHE in the treatment of acute migraine headache. Headache. 1986;26:168\u201371.","journal-title":"Headache."},{"issue":"2","key":"1128_CR68","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/TME.0000000000000296","volume":"42","author":"MH Bilhimer","year":"2020","unstructured":"Bilhimer MH, Groth ME, Holmes AK. Ketamine for migraine in the emergency department. Adv Emerg Nurs J. 2020;42(2):96\u2013102.","journal-title":"Adv Emerg Nurs J"},{"issue":"12","key":"1128_CR69","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/PEC.0b013e3182768a6b","volume":"28","author":"DC Sheridan","year":"2012","unstructured":"Sheridan DC, Spiro DM, Nguyen T, Koch TK, Meckler GD. Low-dose propofol for the abortive treatment of pediatric migraine in the emergency department. Pediatr Emerg Care. 2012;28(12):1293\u20136.","journal-title":"Pediatr Emerg Care"},{"issue":"8","key":"1128_CR70","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/PCC.0000000000001629","volume":"19","author":"MA Ayulo Jr","year":"2018","unstructured":"Ayulo MA Jr, Phillips KE, Tripathi S. Safety and efficacy of IV lidocaine in the treatment of children and adolescents with status migraine. Pediatr Crit Care Med. 2018;19(8):755\u20139.","journal-title":"Pediatr Crit Care Med"},{"issue":"2","key":"1128_CR71","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nurt.2010.03.001","volume":"7","author":"M Levin","year":"2010","unstructured":"Levin M. Nerve blocks in the treatment of headache. Neurotherapeutics. 2010;7(2):197\u2013203.","journal-title":"Neurotherapeutics."},{"issue":"10","key":"1128_CR72","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/head.12939","volume":"56","author":"CL Szperka","year":"2016","unstructured":"Szperka CL, Gelfand AA, Hershey AD. Patterns of use of peripheral nerve blocks and trigger point injections for pediatric headache: results of a survey of the American Headache Society Pediatric and Adolescent Section. Headache. 2016;56(10):1597\u2013607.","journal-title":"Headache."},{"issue":"1","key":"1128_CR73","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s10194-018-0835-5","volume":"19","author":"F Puledda","year":"2018","unstructured":"Puledda F, Goadsby PJ, Prabhakar P. Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation. J Headache Pain. 2018;19(1):5.","journal-title":"J Headache Pain"},{"issue":"2","key":"1128_CR74","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.pediatrneurol.2013.09.008","volume":"50","author":"AA Gelfand","year":"2014","unstructured":"Gelfand AA, Reider AC, Goadsby PJ. Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders. Pediatr Neurol. 2014;50(2):135\u20139.","journal-title":"Pediatr Neurol"},{"key":"1128_CR75","doi-asserted-by":"crossref","unstructured":"Lambrinakos-Raymond K, Dubrovsky A. Nerve blocks in paediatric and adolescent headache disorders. Current Opinion in Pediatrics. 2018;30(6):780-785.","DOI":"10.1097\/MOP.0000000000000687"},{"issue":"5","key":"1128_CR76","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1177\/0333102413512032","volume":"34","author":"S Khan","year":"2014","unstructured":"Khan S, Schoenen J, Ashina M. Sphenopalatine ganglion neuromodulation in migraine: what is the rationale? Cephalagia. 2014;34(5):382\u201391.","journal-title":"Cephalagia."},{"issue":"1","key":"1128_CR77","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/head.12458","volume":"55","author":"R Cady","year":"2015","unstructured":"Cady R, Saper J, Dexter K, Manley HR. A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with Tx360\u00ae as acute treatment for chronic migraine. Headache. 2015;55(1):101\u201316.","journal-title":"Headache."},{"key":"1128_CR78","doi-asserted-by":"crossref","unstructured":"Huguet A, Tougas ME, Hayden J, McGrath PJ, Chambers CT, Stinson JN, Wozney L. Systematic review of childhood and adolescent risk and prognostic factors for recurrent headaches. J Pain. 2016;17(8):855-873.e8.","DOI":"10.1016\/j.jpain.2016.03.010"},{"key":"1128_CR79","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1212\/WNL.0b013e3181eee244","volume":"75","author":"L Robberstad","year":"2010","unstructured":"Robberstad L, Dyb G, Hagen K, Stovner LJ, Holmen TL, Zwart JA. An unfavorable lifestyle and 34 recurrent headaches among adolescents: the HUNT study. Neurology. 2010;75:712\u20137.","journal-title":"Neurology"},{"key":"1128_CR80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pediatrneurol.2019.10.002","volume":"103","author":"R Barmherzig","year":"2020","unstructured":"Barmherzig R, Lagman-Bartolome AM, Marlowe S, Kohut SA, Gunn G, Olivieri H, et al. Headache hygiene in pediatrics: brushing up on the basics. Pediatr Neurol. 2020;103:3\u20137.","journal-title":"Pediatr Neurol"},{"issue":"9","key":"1128_CR81","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629\u2013808.","journal-title":"Cephalalgia."},{"issue":"3","key":"1128_CR82","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/head.13016","volume":"57","author":"QX Ng","year":"2017","unstructured":"Ng QX, Venkatanarayanan N, Kumar L. A systematic review and meta-analysis of the efficacy of cognitive behavioral therapy for the management of pediatric migraine. Headache. 2017;57(3):349\u201362.","journal-title":"Headache."},{"key":"1128_CR83","doi-asserted-by":"crossref","unstructured":"Eccleston C, Palermo TM, Williams A, et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2014;CD003968.","DOI":"10.1002\/14651858.CD003968.pub4"},{"key":"1128_CR84","doi-asserted-by":"publisher","first-page":"1411e1426","DOI":"10.1111\/j.1468-2982.2006.01226.x","volume":"26","author":"E Trautmann","year":"2006","unstructured":"Trautmann E, Lackschewitz H, Kroner-Herwig B. Psychological treatment of recurrent headache in children and adolescents: a meta-analysis. Cephalalgia. 2006;26:1411e1426.","journal-title":"Cephalalgia."},{"issue":"24","key":"1128_CR85","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1001\/jama.2013.282533","volume":"310","author":"SW Powers","year":"2013","unstructured":"Powers SW, Kashikar-Zuck SM, Allen JR, LeCates SL, Slater SK, Zafar M, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA. 2013;310(24):2622\u201330.","journal-title":"JAMA."},{"issue":"2","key":"1128_CR86","doi-asserted-by":"publisher","first-page":"e20160675","DOI":"10.1542\/peds.2016-0675","volume":"138","author":"A Stubberud","year":"2016","unstructured":"Stubberud A, Varkey E, McCrory DC, Pedersen SA, Linde M. Biofeedback as prophylaxis for pediatric migraine: a meta-analysis. Pediatrics. 2016;138(2):e20160675.","journal-title":"Pediatrics."},{"issue":"Suppl 1","key":"1128_CR87","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10072-018-3365-7","volume":"39","author":"E Sansone","year":"2018","unstructured":"Sansone E, Raggi A, Grignani E, Leonardi M, D\u2019Amico D, Scaratti C, et al. Mindfulness meditation for chronic migraine in pediatric population: a pilot study. Neurol Sci. 2018;39(Suppl 1):111\u20133.","journal-title":"Neurol Sci"},{"issue":"5","key":"1128_CR88","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11916-018-0692-6","volume":"22","author":"SL Orr","year":"2018","unstructured":"Orr SL. The evidence for the role of nutraceuticals in the management of pediatric migraine: a review. Curr Pain Headache Rep. 2018;22(5):37.","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"1128_CR89","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/jcm10010138","volume":"10","author":"G Yamanaka","year":"2021","unstructured":"Yamanaka G, Kanou K, Takamatsu T, Takeshita M, Morichi S, Suzuki S, et al. Complementary and integrative medicines as prophylactic agents for pediatric migraine: a narrative literature review. J Clin Med. 2021;10(1):138.","journal-title":"J Clin Med"},{"key":"1128_CR90","unstructured":"Oskoui M, Pringsheim T, Billinghurst L, et al. Practice guideline update summary: pharmacologic treatment for pediatric migraine prevention: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society [published correction appears in Neurology. 2020;94(1):50]. Neurology. 2019;93(11):500-509. This is a comprehensive guideline providing an updated evidence-based recommendation on pharmacologic treatment for migraine prevention in children and adolescents."},{"key":"1128_CR91","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa1610384","volume":"376","author":"SW Powers","year":"2017","unstructured":"Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, et al. Trial of amitriptyline, topiramate, and placebo for 5 pediatric migraine. N Engl J Med. 2017;376:115\u201324.","journal-title":"N Engl J Med"},{"key":"1128_CR92","doi-asserted-by":"crossref","unstructured":"Evers S, Marziniak M, Frese A, Gralow I. Placebo efficacy in childhood and adolescence migraine: 27 an analysis of double-blind and placebo-controlled studies. Cephalalgia. 2009;29:436-444. 28 53.","DOI":"10.1111\/j.1468-2982.2008.01752.x"},{"key":"1128_CR93","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jpeds.2014.06.040","volume":"165","author":"V Faria","year":"2014","unstructured":"Faria V, Linnman C, Lebel A, Borsook D. Harnessing the placebo effect in pediatric migraine 29 clinic. J Pediatr. 2014;165:659\u201365.","journal-title":"J Pediatr"},{"issue":"8","key":"1128_CR94","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s40264-019-00824-3","volume":"42","author":"PK Winner","year":"2019","unstructured":"Winner PK, Blumenfeld AM, Eross EJ, Orejudos AC, Mirjah DL, Adams AM, et al. Long-term safety and tolerability of onabotulinumtoxin A treatment in patients with chronic migraine: results of the COMPEL Study. Drug Saf. 2019;42(8):1013\u201324.","journal-title":"Drug Saf"},{"issue":"1","key":"1128_CR95","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s10194-018-0918-3","volume":"19","author":"M Vikelis","year":"2018","unstructured":"Vikelis M, Argyriou AA, Dermitzakis EV, Spingos KC, Makris N, Kararizou E. Sustained onabotulinumtoxin A therapeutic benefits in patients with chronic migraine over 3 years of treatment. J Headache Pain. 2018;19(1):87.","journal-title":"J Headache Pain"},{"issue":"1","key":"1128_CR96","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s10194-018-0953-0","volume":"20","author":"WB Young","year":"2019","unstructured":"Young WB, Ivan Lopez J, Rothrock JF, Orejudos A, Manack Adams A, Lipton RB, et al. Effects of onabotulinumtoxin A treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study. J Headache Pain. 2019;20(1):12.","journal-title":"J Headache Pain"},{"issue":"6","key":"1128_CR97","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","volume":"50","author":"DW Dodick","year":"2010","unstructured":"Dodick DW, Turkel CC, DeGryse RE, et al. Onabotulinumtoxin A for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010;50(6):921\u201336.","journal-title":"Headache."},{"issue":"2","key":"1128_CR98","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11910-012-0251-1","volume":"12","author":"M Kabbouche","year":"2012","unstructured":"Kabbouche M, O\u2019Brien H, Hershey AD. Onabotulinumtoxin A in pediatric chronic daily headache. Current neurology and neuroscience reports. 2012;12(2):114\u20137.","journal-title":"Current neurology and neuroscience reports"},{"issue":"3","key":"1128_CR99","volume":"11","author":"SS Ali","year":"2019","unstructured":"Ali SS, Bragin I, Rende E, Mejico L, Werner KE. Further evidence that onabotulinum toxin is a viable treatment option for pediatric chronic migraine patients. Cureus. 2019;11(3):e4343.","journal-title":"Cureus."},{"issue":"5","key":"1128_CR100","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.pediatrneurol.2010.06.001","volume":"43","author":"K Ahmed","year":"2010","unstructured":"Ahmed K, Oas KH, Mack KJ, Garza I. Experience with botulinum toxin type A in medically intractable pediatric chronic daily headache. Pediatr Neurol. 2010;43(5):316\u20139.","journal-title":"Pediatr Neurol"},{"issue":"5","key":"1128_CR101","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/JNN.0b013e3181aaa98f","volume":"41","author":"VW Chan","year":"2009","unstructured":"Chan VW, McCabe EJ, MacGregor DL. Botox treatment for migraine and chronic daily headache in adolescents. The Journal of neuroscience nursing: journal of the American Association of Neuroscience Nurses. 2009;41(5):235\u201343.","journal-title":"The Journal of neuroscience nursing: journal of the American Association of Neuroscience Nurses"},{"issue":"12","key":"1128_CR102","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1177\/0883073820931256","volume":"35","author":"R Marcelo","year":"2020","unstructured":"Marcelo R, Freund B. The efficacy of botulinum toxin in pediatric chronic migraine: a literature review. J Child Neurol. 2020;35(12):844\u201351.","journal-title":"J Child Neurol"},{"issue":"9","key":"1128_CR103","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1177\/0883073818776142","volume":"33","author":"S Shah","year":"2018","unstructured":"Shah S, Calderon MD, Wu W, Grant J, Rinehart J. Onabotulinumtoxin A (BOTOX\u00ae) for prophylactic treatment of pediatric migraine: a retrospective longitudinal analysis. J Child Neurol. 2018;33(9):580\u20136.","journal-title":"J Child Neurol"},{"key":"1128_CR104","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1136\/rapm-2020-101605","volume":"46","author":"S Shah","year":"2021","unstructured":"Shah S, Calderon M, Crain N, et al. Effectiveness of onabotulinumtoxin A (BOTOX) in pediatric patients experiencing migraines: a randomized, double-blinded, placebo-controlled crossover study in the pediatric pain population. Reg Anesth Pain Med. 2021;46:41\u20138.","journal-title":"Reg Anesth Pain Med"},{"issue":"10","key":"1128_CR105","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1111\/head.13414","volume":"58","author":"CL Szperka","year":"2018","unstructured":"Szperka CL, VanderPluym J, Orr SL, Oakley CB, Qubty W, Patniyot I, et al. Recommendations on the use of anti-CGRP monoclonal antibodies in children and adolescents. Headache. 2018;58(10):1658\u201369.","journal-title":"Headache."},{"key":"1128_CR106","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pediatrneurol.2020.09.014","volume":"114","author":"KA Greene","year":"2021","unstructured":"Greene KA, Gentile CP, Szperka CL, Yonker M, Gelfand AA, Grimes B, et al. Calcitonin gene-related peptide monoclonal antibody use for the preventive treatment of refractory headache disorders in adolescents. Pediatr Neurol. 2021;114:62\u20137.","journal-title":"Pediatr Neurol"},{"key":"1128_CR107","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejpn.2021.02.008","volume":"32","author":"C B\u00f6rner","year":"2021","unstructured":"B\u00f6rner C, Urban G, Beaulieu LD, Sollmann N, Krieg SM, Straube A, et al. The bottom-up approach: non-invasive peripheral neurostimulation methods to treat migraine: a scoping review from the child neurologist\u2019s perspective. Eur J Paediatr Neurol. 2021;32:16\u201328.","journal-title":"Eur J Paediatr Neurol"},{"key":"1128_CR108","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1056\/NEJMoa1813049","volume":"381","author":"DW Dodick","year":"2019","unstructured":"Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, et al. Ubrogepant for the treatment of migraine. N Engl J Med. 2019;381:2230\u201341.","journal-title":"N Engl J Med"},{"key":"1128_CR109","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1811090","volume":"381","author":"RB Lipton","year":"2019","unstructured":"Lipton RB, Croop R, Stock EG, Stock DA, Morris BA, Frost M, et al. Rimegepant, an oral calcitonin gene-related peptide receptor antagonist, for migraine. N Engl J Med. 2019;381:142\u20139.","journal-title":"N Engl J Med"},{"key":"1128_CR110","doi-asserted-by":"crossref","unstructured":"Wietecha L, Kuca B, Asafu-Adjei J, et al. Phase 3 studies (SAMURAI, SPARTAN) of lasmiditan compared to placebo for acute treatment of migraine (S50.008). Neurology. 2018;90.","DOI":"10.1212\/WNL.90.15_supplement.S50.008"},{"key":"1128_CR111","volume-title":"Komori M","author":"M Tsai","year":"2021","unstructured":"Tsai M, Nery ESM, Kerr L, Khanna R. Komori M. Wilbraham D, Winner P. Pharmacokinetics, safety, and tolerability of lasmiditan in pediatric patients with migraine. Clin Pharmacokinet: Dennehy EB; 2021."}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-021-01128-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-021-01128-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-021-01128-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T07:38:51Z","timestamp":1725176331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-021-01128-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":111,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1128"],"URL":"https:\/\/doi.org\/10.1007\/s11910-021-01128-9","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]},"assertion":[{"value":"27 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"38"}}